SCHEMBL29438916

SCHEMBL29438916

CNS(=O)(=O)c1ccc(Nc2ccc(OC(F)(F)F)cn2)c(-c2cn(C)cn2)c1

nearest known ligand 0.63

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 1/20 0.63
▸ YAP1 P46937 1/20 0.63
▸ TNNI3K Q59H18 9/20 0.49
▸ ALDH1A1 P00352 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ BRAF P15056 7/20 0.43
▸ MAPT P10636 1/20 0.40
▸ IDH1 O75874 1/20 0.38
▸ TLR2 O60603 1/20 0.38
▸ TLR1 Q15399 1/20 0.38
▸ SCN9A Q15858 1/20 0.37
▸ CCR9 P51686 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22718358 1.00 TEAD1 (0.63) TEAD1YAP1TNNI3KALDH1A1MAPK1
SCHEMBL29438880 0.87 TEAD1 (0.77) TEAD1YAP1TNNI3KBRAFMAPT
SCHEMBL22718190 0.87 TEAD1 (0.77) TEAD1YAP1TNNI3KBRAFMAPT
SCHEMBL24788980 0.85 TEAD1 (0.66) TEAD1YAP1TNNI3KBRAFMAPT
SCHEMBL30135282 0.85 TEAD1 (0.66) TEAD1YAP1TNNI3KBRAFMAPT
SCHEMBL22843416 0.84 TEAD1 (0.45) TEAD1YAP1TNNI3KALDH1A1MAPK1
SCHEMBL22718188 0.83 TEAD1 (0.66) TEAD1YAP1TNNI3KALDH1A1BRAF
SCHEMBL29438838 0.83 TEAD1 (0.66) TEAD1YAP1TNNI3KALDH1A1BRAF
SCHEMBL24496007 0.83 TEAD1 (0.58) TEAD1YAP1TNNI3KBRAFMAPT
SCHEMBL29648310 0.83 TEAD1 (0.58) TEAD1YAP1TNNI3KBRAFMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119954725-A TEAD inhibitors and uses thereof 医肯纳肿瘤学公司 2025-05-09 — — CN disclosed
CN-114466839-B TEAD inhibitors and uses thereof 医肯纳肿瘤学公司 2025-01-07 — — CN disclosed
EP-3976194-A2 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback